Interpretation of in vitro-in vivo time profiles in terms of extent, rate, and shape

Pharmaceutical Dissolution Testing

Volumn , Issue , 2005, Pages 251-279

  Langenbucher, Frieder ^a  

^a BioVista LLC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41349089536     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (33)

1. Reppas C, Nicolaides E. Analysis of drug dissolution data. In:Dressman JB, Lennernnäs H, eds. Oral Drug Absorption. New York: Marcel Dekker, 2000.
2. Langenbucher F. Handling of computational in vitro/in vivo correlation problems by Microsoft Excel, part II. Distribution functions and moments. Eur J Pharm Biopharm 2002; 53: 1-7.
3. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol 1972; 24:979-981.
4. Langenbucher F. Parametric representation of dissolution rate curves by the RRSBW distribution. Pharm Ind 1976; 38:472-477.
5. Bennett CA, Franklin NL. Statistical Analysis in Chemistry and the Chemical Industry. New York: John Wiley & Sons, 1963.
6. Johnson NL, Leone FC. Statistics and Experimental Design in Engineering and the Physical Science. New York: John Wiley & Sons, 1977.
7. Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 1978; 6:547-558.
8. Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 1980; 8:509-534.
9. Brockmeier D. Die Rekonstruktion der Freisetzungsprofile Mikoverkapselter Arzneiformen durch den Mittelwert und die Varianz der Freisetzungsprofile. Arzneim Forsch 1981; 31:1746-1751.
10. Tanigawara Y, Yamaoka K, Nakagawa T, Uno T. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products. J Pharm Sci 1982; 71:1129-1133.
11. von Hattingberg HM, Brockmeier D, Vögele D. Momentenanalyse und in vitro-/in vivo-Korrelation. Acta Pharm Technol 1984; 30:93-100.
12. Chanter DO. The determination of mean residence time using statistical moments: is it correct? J Pharmacokinet Biopharm 1985; 13:93-100.
13. Veng-Pedersen P, Gillespie W. The mean residence time of drugs in the systemic circulation. J Pharm Sci 1985; 74:791-792.
14. Brockmeier D. In vitro/in vivo correlation of dissolution using moments of dissolution and transit times. Acta Pharm Technol 1986; 32:164-174.
15. Khoo KC, Gibaldi M, Brazzell RK. Comparison of statistical moment parameters to cmax and tmax for detecting differences in in vivo dissolution rates. J Pharm Sci 1985; 74:1340-1342.
16. Chow SC, Ki FYC. Statistical comparison between dissolution profiles of drug products. J Biopharm Stat 1997; 7:241-258.
17. Freitag G. Guidelines on dissolution profile comparison. Drug Inf J 2001; 35:865-874.
18. Rescigno A. Bioequivalence. Pharm Res 1992; 9:925-928.
19. Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996; 20:64-74.
20. Liu JP, Ma MC, Chow SC. Statistical evaluation of the similarity factor f2 as a criterion for assessment of similarity between dissolution profiles. Drug Inf J 1997; 31:1255-1271.
21. Shah VP, Tsong Y, Sathe P, Liu JP. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm Res 1998; 15:889-896.
22. Langenbucher F. IVIVC indices for comparing release and response profiles. Drug Dev Ind Pharm 1999; 25:1223-1225.
23. Polli JE, Rekhi GS, Shah VP. Methods to compare dissolution profiles. Drug Inf J 1996; 30:1113-1120.
24. Marston SA, Polli JE. Evaluation of direct curve comparison metrics applied to pharmacokinetic profiles and relative bioavailability and bioequivalence. Pharm Res 1997; 14:1363-1369.
25. Polli JE, Rekhi GS, Augsburger LL, Shah VP. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci 1997; 86:690-700.
26. Polli JE, McLean AM. Novel direct curve comparison metrics for bioequivalence. Pharm Res 2001; 18:734-741.
27. Chinchilli VM, Elswick RK. The multivariate assessment of bioequivalence. J Biopharm Stat 1997; 7:113-123.
28. Tsong Y, Hammerstrom T, Sathe P, Shah VP. Statistical assessment of mean differences between two dissolution data sets. Drug Inf J 1996; 30:1105-1112.
29. Sathe PM, Tsong Y, Shah VP. In vitro dissolution profile comparison:statistics and analysis, model dependent approach. Pharm Res 1996; 13:1799-1803.
30. Sathe P, Tsong Y, Shah VP. In vitro dissolution profile comparison and IVIVR, carbamazepine case. In: Young D, Devane JG, Butler J, eds. In Vitro-in Vivo Correlations. New York: Plenum Press, 1997:31-42.
31. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. NewYork: Chapman & Hall, 1994.
32. Hunt CA, Givens GH, Guzy S. Bootstrapping for pharmacokinetic models: visualization of predictive and parameter uncertainty. Pharm Res 1998; 15:690-697.
33. Broberg P. Estimation of relative SD. Drug Dev Ind Pharm 1999; 25:37-43.